Combination therapy with erythropoietin, magnesium sulfate and hypothermia for hypoxic-ischemic encephalopathy: an open-label pilot study to assess the safety and feasibility

Combination therapy with erythropoietin, magnesium sulfate and hypothermia for hypoxic-ischemic encephalopathy: an open-label pilot study to assess the safety and feasibility

Abstract Background Although therapeutic hypothermia improves the outcome of neonatal hypoxic-ischemic encephalopathy (HIE), its efficacy is still limited. This preliminary study evaluates the safety and feasibility of the combination therapy with erythropoietin (Epo), magnesium sulfate and hypother...

Full description

Bibliographic Details
Main Authors: Miho Nonomura, Sayaka Harada, Yuki Asada, Hisako Matsumura, Hiroko Iwami, Yuko Tanaka, Hiroyuki Ichiba
Format: Article
Language:English
Published: BMC 2019-01-01
Series:BMC Pediatrics
Subjects:
Hypoxic-ischemic encephalopathy
Erythropoietin
Magnesium sulfate
Therapeutic hypothermia
Online Access:http://link.springer.com/article/10.1186/s12887-018-1389-z

Internet

http://link.springer.com/article/10.1186/s12887-018-1389-z

Similar Items